The RTOG trial 8911 did, however, describe a highly significant improvement in survival for patients in the NACS cohort who demonstrated (by way of barium study) a significant response to chemotherapy.
← all excerpts
Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy.
1
—
—